All Events
// THE ‘SCHREMS II’ DECISION: IS IT STILL POSSIBLE TO EXCHANGE PERSONAL DATA FROM CLINICAL TRIALS BETWEEN EU AND US IN COMPLIANCE WITH GDPR: STATUS AND CONSEQUENCES
- This event has passed.
Event:
THE ‘SCHREMS II’ DECISION: IS IT STILL POSSIBLE TO EXCHANGE PERSONAL DATA FROM CLINICAL TRIALS BETWEEN EU AND US IN COMPLIANCE WITH GDPR: STATUS AND CONSEQUENCES
Date:
January 28, 2021 @ 4:30 pm - 5:30 pm
Description
In July 2020, in the so-called “Schrems II” decision, the Court of Justice of the European Union declared the European Commission’s Privacy Shield Decision invalid, thereby making transfers of personal data on the basis of the Privacy Shield Decision illegal. Furthermore, the Court stipulated stricter requirements for the transfer of personal data based on standard contract clauses (SCCs).
During this interactive webinar, Hans Graux will explain more in detail this Schrems II decision, the consequences for the transfer of personal data between EU and US, the current status and an outlook for the future.